CTMS Selection White Paper: The Whole Product Approach
Deriving real value from investments in clinical research management systems requires long-term vision and carefully honed selection criteria. The evaluation and selection process can be enhanced by utilizing a technique known as the "Whole Product" approach.
The Whole Product approach looks at the entire ecosystem that is created by a CTMS, its adoption within the research site, and the technology provider. Aspects of this approach encompass: (1) the current product, (2) release management, (3) training, (4) adoption, (5) integration, (6) community, and (7) innovation.
The assessment process is largely dependent on the distinct needs of different types of research institutions. Forte has two versions of the Whole Product approach available in white paper format: One provides guidance for enterprise institutions that manage robust portfolios of clinical trials, and the other provides guidance for sites, site networks and trial management organizations engaged in industry-sponsored trials.
Download the White Paper for the Enterprise
For academic medical centers, cancer centers, research hospitals and children's hospitals managing robust portfolios of clinical trials including investigator initiated trials, this white paper outlines how the OnCore Product Family applies the Whole Product approach to enterprise-class clinical research management.
Download the White Paper for Sites
For investigator sites, research groups, investigator site networks, and trial management organizations engaged in industry sponsored trials, this white paper outlines how the Allegro Product Family applies the Whole Product approach to CTMS.
.